The lawsuit was filed in the name of three staff members at the Egyptian Initiative for Personal Rights (EIPR) because the new system threatened the accessibility and affordability of drugs in Egypt, especially the price of generic drugs, which Egyptian citizens rely heavily due to their relative low cost. Previous to this decree, the price of generic drugs was determined on the basis of the actual production cost, plus profit mark-ups.